1000 related articles for article (PubMed ID: 24699310)
1. The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
Molnar A; Fu S; Lewis J; Allsop DJ; Copeland J
Forensic Sci Int; 2014 May; 238():113-9. PubMed ID: 24699310
[TBL] [Abstract][Full Text] [Related]
2. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
[TBL] [Abstract][Full Text] [Related]
3. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
4. Orally administered cannabidiol does not produce false-positive tests for Δ
McCartney D; Kevin RC; Suraev AS; Irwin C; Grunstein RR; Hoyos CM; McGregor IS
Drug Test Anal; 2022 Jan; 14(1):137-143. PubMed ID: 34412166
[TBL] [Abstract][Full Text] [Related]
5. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantification of THC-COOH, OH-THC, and further cannabinoids in human hair by gas chromatography-tandem mass spectrometry with electron ionization applying automated sample preparation.
Kieliba T; Lerch O; Andresen-Streichert H; Rothschild MA; Beike J
Drug Test Anal; 2019 Feb; 11(2):267-278. PubMed ID: 30144294
[TBL] [Abstract][Full Text] [Related]
8. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
[TBL] [Abstract][Full Text] [Related]
10. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.
Anizan S; Bergamaschi MM; Barnes AJ; Milman G; Desrosiers N; Lee D; Gorelick DA; Huestis MA
Drug Test Anal; 2015 Feb; 7(2):114-20. PubMed ID: 24995604
[TBL] [Abstract][Full Text] [Related]
11. Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.
Karschner EL; Darwin WD; Goodwin RS; Wright S; Huestis MA
Clin Chem; 2011 Jan; 57(1):66-75. PubMed ID: 21078841
[TBL] [Abstract][Full Text] [Related]
12. Sativex
Markovà J; Essner U; Akmaz B; Marinelli M; Trompke C; Lentschat A; Vila C
Int J Neurosci; 2019 Feb; 129(2):119-128. PubMed ID: 29792372
[TBL] [Abstract][Full Text] [Related]
13. [Simultaneous determination of delta-9-tetrahydrocannabinol cannabidiol and cannabinol in edible oil using ultra performance liquid chromatography-tandem mass spectrometry].
Zhang A; Wang Q; Mo S
Se Pu; 2010 Nov; 28(11):1015-9. PubMed ID: 21381415
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.
Milman G; Barnes AJ; Lowe RH; Huestis MA
J Chromatogr A; 2010 Feb; 1217(9):1513-21. PubMed ID: 20083251
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids determination in oral fluid by SPME-GC/MS and UHPLC-MS/MS and its application on suspected drivers.
Anzillotti L; Castrignanò E; Strano Rossi S; Chiarotti M
Sci Justice; 2014 Dec; 54(6):421-6. PubMed ID: 25498928
[TBL] [Abstract][Full Text] [Related]
16. Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds.
Molnar A; Fu S
Bioanalysis; 2016 Apr; 8(8):829-45. PubMed ID: 27005853
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship.
Contin M; Mancinelli L; Perrone A; Sabattini L; Mohamed S; Scandellari C; Foschi M; Vacchiano V; Lugaresi A; Riva R
Clin Neuropharmacol; 2018; 41(5):171-176. PubMed ID: 30024443
[TBL] [Abstract][Full Text] [Related]
18. Are cannabinoids detected in hair after washing with Cannabio shampoo?
Cirimele V; Kintz P; Jamey C; Ludes B
J Anal Toxicol; 1999 Sep; 23(5):349-51. PubMed ID: 10488922
[TBL] [Abstract][Full Text] [Related]
19. Sativex for the management of multiple sclerosis symptoms.
Perras C
Issues Emerg Health Technol; 2005 Sep; (72):1-4. PubMed ID: 16317825
[TBL] [Abstract][Full Text] [Related]
20. Advances in the management of multiple sclerosis spasticity: recent clinical trials.
Fernández O
Eur Neurol; 2014; 72 Suppl 1():9-11. PubMed ID: 25278117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
